1,164
Participants
Start Date
August 2, 2023
Primary Completion Date
May 31, 2025
Study Completion Date
May 31, 2026
Aspirin
Experimental drug administrated orally
Placebo
Treatment for the control group
RECRUITING
CHU Angers, Angers
RECRUITING
CHU Bordeaux, Bordeaux
RECRUITING
CHU Clermont-Ferrand, Clermont-Ferrand
RECRUITING
CHU Dijon-Bourgogne, Dijon
RECRUITING
CHU Lille, Lille
RECRUITING
HCL - Groupement Hospitalier Est, Hôpital Femme Mère Enfant, Lyon
RECRUITING
AP-HM Hôpital de la Conception, Marseille
RECRUITING
AP-HM Hôpital Nord, Marseille
RECRUITING
CHU Montpellier, Montpellier
RECRUITING
CHRU Nancy, Nancy
RECRUITING
CHU Nantes, Nantes
RECRUITING
CHU Nîmes, Nîmes
RECRUITING
Groupe hospitalier St Joseph, Paris
NOT_YET_RECRUITING
Hôpital Armand - Trousseau, Paris
RECRUITING
Hôpital Cochin, Paris
RECRUITING
CHI Poissy Saint Germain en Laye, Poissy
NOT_YET_RECRUITING
CHU Poitiers, Poitiers
RECRUITING
CHU Rennes, Rennes
RECRUITING
CHU Saint Etienne, Hôpital Nord, Saint-Etienne
RECRUITING
CHU Strasbourg, Strasbourg
RECRUITING
CHU Toulouse, Toulouse
University Hospital, Toulouse
OTHER